rivastigmine has been researched along with Long QT Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riepe, MW | 1 |
| Inglis, F | 1 |
| Dourish, J; Walsh, E | 1 |
1 trial(s) available for rivastigmine and Long QT Syndrome
| Article | Year |
|---|---|
High-dose cholinergic therapy with rivastigmine patch does not prolong QTc time in patients with Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Electrophysiological Phenomena; Heart; Humans; Long QT Syndrome; Phenylcarbamates; Rivastigmine; Transdermal Patch | 2014 |
2 other study(ies) available for rivastigmine and Long QT Syndrome
| Article | Year |
|---|---|
Rivastigmine and QT interval prolongation.
Topics: Carbamates; Cholinesterase Inhibitors; Humans; Long QT Syndrome; Neuroprotective Agents; Phenylcarbamates; Rivastigmine | 2003 |
Prolonged QT interval with rivastigmine.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Long QT Syndrome; Male; Neuroprotective Agents; Phenylcarbamates; Rivastigmine | 2002 |